Here is a quick look at some of the drugs most recently FDA-approved for primary care diseases.
Fluad is an inactivated flu vaccine for prevention of seasonal influenza. Â©Volt Collection/Shutterstock.com
Naloxone, an intranasal opioid antagonist formulation, is used in the emergency treatment of opioid overdose.Â©ChameleonsEye/Shutterstock.com
Genvoya is indicated as a complete regimen for HIV-1 infection in ART-naÃ¯ve patients â¥ age 12 or to replace current ART regimen in certain patients.Â©martynowi.cz/Shutterstock.com
Nucala is indicated for add-on maintenance treatment in severe eosinophilic asthma.Â©Complot-Shutterstock.com
Belbuca, a partial opioid agonist analgesic in a buccal film formulation, is used to manage chronic pain. Â©decade3d - anatomy online/Shutterstock.com
Ryzodeg 70/30, Tresiba, and Synjardy-were all approved to improve glycemic control in adults with diabetes mellitus.
An extended release aspirin formulation, Durlaza is indicated for secondary prevention of stroke and acute cardiovascular events. Â©SpeedkingZ/Shutterstock.com
Addyi is indicated for hypoactive sexual desire disorder in premenopausal women. Â©Lightspring/Shutterstock.com
Repatha is indicated in the management of familial hypercholesterolemia.Â©Tyler Olson/Shutterstock.com
Entresto is used to reduce risk of CV death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction.
The FDA approved a host of new drugs in 2015. Here is a very brief look at some the most recently approved.Sourceshttp://www.centerwatch.com/drug-information/fda-approved-drugs/http://www.drugs.com/newdrugs.html